Accéder au contenu
Merck

Susceptibility of Encephalitozoon cuniculi to several drugs in vitro.

Antimicrobial agents and chemotherapy (1995-06-01)
F F Franssen, J T Lumeij, F van Knapen
RÉSUMÉ

In the light of the increased incidence of human Encephalitozoon infections and the absence of an established treatment protocol, a simple in vitro testing method to compare activities of drugs against Encephalitozoon cuniculi was developed. With this in vitro method, the 50% inhibitory concentrations of fumagillin, thiabendazole, albendazole, oxibendazole, and propamidine isethionate for E. cuniculi in rabbit kidney cells were determined. Itraconazole, toltrazuril, metronidazole, ronidazole, and ganciclovir were ineffective in this testing system.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Oxibendazol, ~98%
Supelco
Oxibendazol, VETRANAL®, analytical standard